Journal of Cardiovascular Electrophysiology

“Virtual Research” May Point the Way Towards Future Device Programming Trials

JENNIFER D. COHEN M.D.

Cardiac Electrophysiology Laboratory, Heart and Vascular Institute, University of North Carolina, Chapel Hill, North Carolina, USA

Search for more papers by this author

J. PAUL MOUNSEY M.D., Ph.D.,

J. PAUL MOUNSEY M.D., Ph.D.

Cardiac Electrophysiology Laboratory, Heart and Vascular Institute, University of North Carolina, Chapel Hill, North Carolina, USA

Search for more papers by this author

JENNIFER D. COHEN M.D.,

JENNIFER D. COHEN M.D.

Cardiac Electrophysiology Laboratory, Heart and Vascular Institute, University of North Carolina, Chapel Hill, North Carolina, USA

Search for more papers by this author

J. PAUL MOUNSEY M.D., Ph.D.,

J. PAUL MOUNSEY M.D., Ph.D.

Cardiac Electrophysiology Laboratory, Heart and Vascular Institute, University of North Carolina, Chapel Hill, North Carolina, USA

Search for more papers by this author

First published: 16 December 2010

https://doi.org/10.1111/j.1540-8167.2010.01978.x

Citations: 1

Address for correspondence: J. Paul Mounsey, M.D., Ph.D., CB7075, 160 Dental Circle, Chapel Hill, NC 27599, USA. Fax: +1-919-966-4366; E-mail: [email protected]

J Cardiovasc Electrophysiol, Vol. 22, pp. 290-292, March 2011.

Dr. Mounsey reports compensation for participation on a speaker's bureau from sanofi-aventis, honoraria relevant to this topic from Medtronic, Boston Scientific, and St. Jude Medical, and serves as a consultant to or on advisory boards of Medtronic and St. Jude Medical. Dr. Cohen reported no potential conflicts of interest.

Share a link

Email
Wechat
Bluesky

References

1 Germano JJ, Reynolds M, Essebag V, Josephson ME: Frequency and causes of implantable cardioverter-defibrillator therapies: Is device therapy proarrhythmic? Am J Cardiol 2006; 97: 1255-1261.
10.1016/j.amjcard.2005.11.048
PubMed Web of Science® Google Scholar
2 Sweeney MO, Wathen MS, Volosin K, Abdalla I, DeGroot PJ, Otterness MF, Stark AJ: Appropriate and inappropriate ventricular therapies, quality of life, and mortality among primary and secondary prevention implantable cardioverter defibrillator patients: Results from the pacing fast VT REduces shock ThErapies (PainFREE Rx II) Trial. Circulation 2005; 111: 2898.
10.1161/CIRCULATIONAHA.104.526673
CAS PubMed Web of Science® Google Scholar
3 Mark DB, Anstrom KJ, Sun JL, Clapp-Channing NE, Tsiatis AA, Davidson-Ray L, Lee KL, Bardy GH: Quality of life with defibrillator therapy or amiodarone in heart failure. N Engl J Med 2008; 359: 999-1008.
10.1056/NEJMoa0706719
CAS PubMed Web of Science® Google Scholar
4 Daubert JP, Zareba W, Cannom DS, McNitt S, Rosero SZ, Wang P, Schuger C, Steinberg JS, Higgins SL, Wilber DJ, Klein H, Andrews ML, Hall WJ, Moss AJ: Inappropriate implantable cardioverter-defibrillator shocks in the MADIT II study: Frequency, mechanisms, predictors, and survival impact. J Am Coll Cardiol 2008; 51: 1357-1365.
10.1016/j.jacc.2007.09.073
PubMed Web of Science® Google Scholar
5 Poole JE, Johnson GW, Hellkamp AS, Anderson J, Callans DJ, Raitt MH, Reddy RK, Marchlinski FE, Yee R, Guarnieri T, Talajic M, Wilber DJ, Fishbein DP, Packer DL, Mark DB, Lee KL, Bardy GH: Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med 2008; 359: 1009-1101.
10.1056/NEJMoa071098
CAS PubMed Web of Science® Google Scholar
6 Sweeney MO, Sherfesse L, DeGroot PJ, Wathen MS, Wilcoff BL: Differences in effects of electrical therapy type for ventricular arrhythmias on mortality in implantable cardioverter-defibrillator patients. Heart Rhythm 2010; 7: 353-360.
10.1016/j.hrthm.2009.11.027
PubMed Web of Science® Google Scholar
7 Wilkoff BL, Ousdigian KT, Sterns LD, Wang ZJ, Wilson RD, Morgan JM: A comparison of empiric to physician-tailored programming of implantable cardioverter-defibrillators. J Am Coll Cardiol 2006; 48: 330-333.
10.1016/j.jacc.2006.03.037
PubMed Web of Science® Google Scholar
8 Friedman PA, McClelland RL, Bamlet WR, Acosta H, Kessler D, Munger TM, Kavesh NG, Wood M, Daoud E, Massumi A, Schuger C, Shorofsky S, Wilcoff B, Glikson M: Dual-chamber versus single-chamber detection enhancements for implantable defibrillator rhythm diagnosis circulation. 2006; 113: 2871-2287.
Google Scholar
9 Wathen MS, DeGroot PJ, Sweeney MO, Stark AJ, Otterness MF, Adkisson WO, Canby RC, Khalighi K, Machado C, Rubenstein DS, Volosin KJ: Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter-defibrillators circulation. 2004; 110: 2591-2596.
Google Scholar
10 Wilcoff BL, Williamson BD, Stern RS, Moore SL, Lu F, Lee SW, Birgersdotter-Green UM, Wathen MS, Van Gelder IC, Heubner BM, Brown ML, Holloman KK: Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients. J Am Coll Cardiol 2008; 52: 541-555.
10.1016/j.jacc.2008.05.011
PubMed Web of Science® Google Scholar
11 Young JB, Abraham WT, Smith AL, Leon A, Lieberman R, Wilkoff B, Canby RC, Schroeder JS, Liem LB, Hall S, Wheelan K: Multicenter InSynch ICD randomized clinical evaluation (MIRACLE-ICD). JAMA 2003; 289: 2685-2694.
10.1001/jama.289.20.2685
PubMed Web of Science® Google Scholar
12 Volosin KJ, Exner DV, Wathen MS, Sherfesee L, Scinicariello AP, Gillberg JM: Combining shock reduction strategies to enhance ICD therapy: A role for computer modeling. J Cardiovasc Electrophysiol; doi:10.1111/j.1540-8167.2010.01918.x.
Google Scholar

Citing Literature

Volume22, Issue3

March 2011

Pages 290-292

“Virtual Research” May Point the Way Towards Future Device Programming Trials

References

Citing Literature

References

Information

About Wiley Online Library

Help & Support

Opportunities

Connect with Wiley

“Virtual Research” May Point the Way Towards Future Device Programming Trials

References

Citing Literature

References

Related

Information